1. Home
  2. PASG vs SCNX Comparison

PASG vs SCNX Comparison

Compare PASG & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PASG
  • SCNX
  • Stock Information
  • Founded
  • PASG 2017
  • SCNX 2010
  • Country
  • PASG United States
  • SCNX United States
  • Employees
  • PASG N/A
  • SCNX N/A
  • Industry
  • PASG Biotechnology: Pharmaceutical Preparations
  • SCNX Other Pharmaceuticals
  • Sector
  • PASG Health Care
  • SCNX Health Care
  • Exchange
  • PASG Nasdaq
  • SCNX Nasdaq
  • Market Cap
  • PASG 31.1M
  • SCNX 33.6M
  • IPO Year
  • PASG 2020
  • SCNX 2020
  • Fundamental
  • Price
  • PASG $0.34
  • SCNX $0.88
  • Analyst Decision
  • PASG Strong Buy
  • SCNX
  • Analyst Count
  • PASG 3
  • SCNX 0
  • Target Price
  • PASG $7.67
  • SCNX N/A
  • AVG Volume (30 Days)
  • PASG 192.0K
  • SCNX 284.4K
  • Earning Date
  • PASG 05-13-2025
  • SCNX 05-10-2025
  • Dividend Yield
  • PASG N/A
  • SCNX N/A
  • EPS Growth
  • PASG N/A
  • SCNX N/A
  • EPS
  • PASG N/A
  • SCNX 2.68
  • Revenue
  • PASG N/A
  • SCNX $136,643.00
  • Revenue This Year
  • PASG N/A
  • SCNX N/A
  • Revenue Next Year
  • PASG N/A
  • SCNX N/A
  • P/E Ratio
  • PASG N/A
  • SCNX $1.24
  • Revenue Growth
  • PASG N/A
  • SCNX N/A
  • 52 Week Low
  • PASG $0.30
  • SCNX $0.69
  • 52 Week High
  • PASG $1.64
  • SCNX $23.77
  • Technical
  • Relative Strength Index (RSI)
  • PASG 41.07
  • SCNX N/A
  • Support Level
  • PASG $0.31
  • SCNX N/A
  • Resistance Level
  • PASG $0.40
  • SCNX N/A
  • Average True Range (ATR)
  • PASG 0.05
  • SCNX 0.00
  • MACD
  • PASG 0.00
  • SCNX 0.00
  • Stochastic Oscillator
  • PASG 30.00
  • SCNX 0.00

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

About SCNX Scienture Holdings Inc. Common Stock

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Share on Social Networks: